These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 13509617)

  • 41. [Clinical experience with the antihistaminic rodismin in dermatology].
    RICHTER H
    Dtsch Gesundheitsw; 1954 Mar; 9(10):312-5. PubMed ID: 13191019
    [No Abstract]   [Full Text] [Related]  

  • 42. The action of thenaldine tartrate (sandostene) in atopic dermatitis; evaluation of a new antiallergic preparation for control of pruritus and treatment of various allergic dermatoses.
    GARBE W
    Can Med Assoc J; 1958 Sep; 79(5):378-80. PubMed ID: 13573282
    [No Abstract]   [Full Text] [Related]  

  • 43. [Ambulant treatment of dermatological diseases with andantol jelly].
    KEMPER A
    Medizinische; 1959 May; 4(20):988-90. PubMed ID: 13673835
    [No Abstract]   [Full Text] [Related]  

  • 44. TOPICAL application of histamine antagonists.
    Lancet; 1953 Jan; 1(6751):126-7. PubMed ID: 13011980
    [No Abstract]   [Full Text] [Related]  

  • 45. [On the significance of the protective action of antihistaminics in the field of dermatology].
    Wodniansky P
    Wien Klin Wochenschr; 1965 Dec; 77(51):1003-7. PubMed ID: 4162113
    [No Abstract]   [Full Text] [Related]  

  • 46. [Antihistaminics in dermatology].
    Karadaglić Dj; Ristić B
    Vojnosanit Pregl; 1999; 56(3):283-8. PubMed ID: 10518448
    [No Abstract]   [Full Text] [Related]  

  • 47. [Value of antihistaminic therapy in the treatment of the hyperfollicular syndrome; trial of 1-(2-benzylanilinoethyl)-pyrrolidine].
    CAPORAL R
    Vie Med; 1958 Jan; 39():99 passim. PubMed ID: 13530641
    [No Abstract]   [Full Text] [Related]  

  • 48. [Clinical experience report of a new antihistaminic (Sandosten) and its combination with calcium Sandoz (Sandosten calcium)].
    NASEMANN T
    Munch Med Wochenschr; 1955 Feb; 97(8):236-8. PubMed ID: 14356153
    [No Abstract]   [Full Text] [Related]  

  • 49. Oral treatment of pruritic dermatoses with a new antihistaminic compound.
    KILE RL
    Antibiotic Med Clin Ther (New York); 1958 Sep; 5(9):578-81. PubMed ID: 13571963
    [No Abstract]   [Full Text] [Related]  

  • 50. Treatment of pruritic dermatoses with chlorpheniramine maleate and prednisone in combination (metreton).
    LACKENBACHER RS
    Ann Allergy; 1957; 15(4):409-13. PubMed ID: 13470685
    [No Abstract]   [Full Text] [Related]  

  • 51. Pharmacological properties of a new antihistaminic agent, phenyltoloxamine (Bristamin).
    HOEKSTRA JB; TISCH DE; RAKIETEN N; DICKISON HL
    J Am Pharm Assoc Am Pharm Assoc; 1953 Oct; 42(10):587-93. PubMed ID: 13096396
    [No Abstract]   [Full Text] [Related]  

  • 52. Treatment of various dermatoses with an oral topical and parenteral antipruritic.
    BAKER KC
    Ariz Med; 1957 Jun; 14(6):329-32. PubMed ID: 13425878
    [No Abstract]   [Full Text] [Related]  

  • 53. [Therapeutic tests with a new antihistaminic with prolonged action, a derivative of piperazine].
    BARAC G; BRAKIER T
    Rev Med Liege; 1952 May; 7(10):313-5. PubMed ID: 14949777
    [No Abstract]   [Full Text] [Related]  

  • 54. [The antihistaminic preparation Tavegil in the treatment of certain dermatoses].
    Prokopchuk AIa; Eremenko SA; Sosnovskiĭ AT; Gilevskaia VF; Korsun VF
    Vestn Dermatol Venerol; 1969 Nov; 43(11):82-4. PubMed ID: 4392871
    [No Abstract]   [Full Text] [Related]  

  • 55. [Experimental and clinical comparative tests of new antihistaminics of the benzimidazole series].
    KIMMIG J
    Actas Dermosifiliogr; 1953 May; 44(8):597-604. PubMed ID: 13114091
    [No Abstract]   [Full Text] [Related]  

  • 56. [Therapeutic evaluation of a new antihistaminic: HS-592].
    Guimarães NA; Fonseca O
    Hospital (Rio J); 1968 Nov; 74(5):1511-4. PubMed ID: 4388711
    [No Abstract]   [Full Text] [Related]  

  • 57. [Experience with a new antihistaminic (Tavegyl, Sandoz) in a dermatologic-allergologic practice].
    Wortmann F
    Dermatol Wochenschr; 1968 Nov; 154(48):1129-33. PubMed ID: 4389418
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical evaluation of a new antihistaminic drug in dermatologic diseases].
    Andri L
    Minerva Dermatol; 1967 Sep; 42(9):479-83. PubMed ID: 4389845
    [No Abstract]   [Full Text] [Related]  

  • 59. [Experience with a new Soviet antihistaminic drug, phencarol, in dermatology].
    Borisenko KK; Butov IuS; Korotkiĭ NG; Abaeva AS
    Vestn Dermatol Venerol; 1977 Apr; (4):72-5. PubMed ID: 19900
    [No Abstract]   [Full Text] [Related]  

  • 60. [Clinical study on a new synthetic antihistaminic: trans-1-(4-methylphenyl)-1-(2-pyridyl)-3-pyrrolidinoprop-1-one chlorhydrate].
    WOLFROMM R; LIACOPOULOS P
    Sem Med Prof Med Soc; 1957 Apr; 33(13):559-61. PubMed ID: 13467333
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.